Product Information
MOUNJARO 5 MG/0.5 ML PEN is a brand product labeled by Eli Lilly and Company, priced at $538.6327 per ML under NDC 00002149580. Its NADAC has been published 202 times since Aug 17, 2022.
Strength
5 mg/.5mL
Manufacturer
Eli Lilly and CompanyNDC
00002149580
Classification
Brand
Dosage Form
INJECTION, SOLUTION
Route
SUBCUTANEOUS
Last Updated
6/17/2026
Active Ingredients
TIRZEPATIDEApproval Type
New Drug (NDA)
FDA Application
NDA215866On Market Since
5/13/2022
Pharmacological Classes
Price Statistics
The NADAC for MOUNJARO 5 MG/0.5 ML PEN has been published 202 times since Aug 17, 2022, and over the history we have for it it has risen 15.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $538.6327 per ML |
|---|---|
| All-time high | $538.7438 (May 13, 2026) |
| All-time low | $466.3413 (Aug 17, 2022) |
| 52-week high | $538.7438 |
| 52-week low | $522.7201 |
| Median price | $515.9080 |
| Average price | $508.9115 |
| Largest weekly change | +5.0% (Jan 11, 2023) |
| Weeks tracked | 202 |
| Tracking since | Aug 17, 2022 |
Generic Alternatives
The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 2% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of MOUNJARO 5 MG/0.5 ML PEN?
The current National Average Drug Acquisition Cost (NADAC) for MOUNJARO 5 MG/0.5 ML PEN, manufactured by Eli Lilly and Company, is $538.6327 per ML (NDC 00002149580), effective Jun 24, 2026.
How has the price of MOUNJARO 5 MG/0.5 ML PEN changed over time?
Over the history we have for it, the NADAC for MOUNJARO 5 MG/0.5 ML PEN has risen 15.5%. It has been tracked across 202 weekly CMS publications since Aug 17, 2022.
What are the highest and lowest recorded NADAC prices for MOUNJARO 5 MG/0.5 ML PEN?
Since Aug 17, 2022, the NADAC for MOUNJARO 5 MG/0.5 ML PEN has ranged from a low of $466.3413 (Aug 17, 2022) to a high of $538.7438 (May 13, 2026), with a median of $515.9080 per ML.
Are there cheaper alternatives to MOUNJARO 5 MG/0.5 ML PEN?
Yes. 1 NADAC-published product shares the same active ingredient, strength, and dosage form. The lowest-priced option, ZEPBOUND 5 MG/0.5 ML PEN, is $525.8935 per ML — about 2% below MOUNJARO 5 MG/0.5 ML PEN.
Who manufactures MOUNJARO 5 MG/0.5 ML PEN?
MOUNJARO 5 MG/0.5 ML PEN (NDC 00002149580) is labeled by Eli Lilly and Company, and CMS classifies it as a brand product.
Related Drugs
Same classification